Gilead Foundation Awards $12 Million to Empower Community Health Workers and Expand HIV Prevention Initiatives Across 14 States and the District of Columbia
MWN-AI** Summary
The Gilead Foundation has announced a significant $12 million investment aimed at empowering community health workers (CHWs) and expanding HIV prevention initiatives across 14 states and the District of Columbia. This funding, allocated to 33 community-based organizations, is part of the Community Health Worker Comprehensive HIV Prevention Initiative and will extend over two years. The primary focus is on enhancing CHW-led prevention models to provide better access to HIV-related information, care navigation, and services for communities disproportionately affected by HIV.
Keeley Cain Wettan, Executive Vice President at Gilead Sciences, emphasized the critical role of CHWs as trusted connections within their communities, stressing that effective HIV prevention requires both medical advancements and culturally responsive systems that address social obstacles. The initiative aims to bolster infrastructure and training for CHWs, allowing them to create sustainable, locally-driven networks for HIV prevention, particularly targeting Black and Latino communities, cisgender and transgender women, people who inject drugs, and youth.
Grants will enable organizations to expand integrated screenings, deliver tailored education, and connect individuals to vital services, thus reducing stigma and enhancing community participation. For example, Bebashi – Transition to Hope in Philadelphia expressed excitement over the grant, highlighting how it aligns with their mission of holistic community health support.
Among the diverse grantees, organizations across various states plan to implement peer navigator models, mentorship, and pharmacy-based training, ensuring the long-term capacity of community health initiatives. Gilead’s broader commitment to innovation and public health preparedness continues as it seeks to improve health outcomes and address inequalities in healthcare access.
MWN-AI** Analysis
The Gilead Foundation's recent announcement of a significant $12 million investment in 33 community-based organizations aimed at enhancing HIV prevention initiatives underscores a crucial trend in health care—community-led interventions are becoming increasingly recognized as vital to addressing public health challenges, particularly in marginalized populations.
As an investor or financial analyst, this initiative signals a strengthening of Gilead Sciences, Inc. (Nasdaq: GILD) in its commitment to social responsibility, which can have a positive impact on its stock performance. Companies that show genuine concern for community health and social equity tend to build stronger reputational capital, leading to long-term investor confidence.
Analyzing Gilead's broader strategy, the focus on integrating community health workers (CHWs) aligns with a growing body of evidence that emphasizes the effectiveness of localized, trust-centered approaches in health service delivery. The commitment to training CHWs not only enhances service accessibility but also ensures that health disparities—particularly among Black, Latino, and LGBTQ+ communities—are systematically addressed.
The grant represents a strategic move into a sector increasingly prioritized by stakeholders. The potential for improved health outcomes could lead to reduced health care costs long-term, a factor that both private and public insurers recognize favorably. Moreover, this initiative may pave the way for increased governmental support, as agencies are likely to align with organizations demonstrating tangible commitment to health equity, thus further solidifying Gilead's presence in the sector.
In this light, financial analysts should monitor Gilead’s evolving community health projects as indicators of its operational effectiveness and responsiveness to social trends. While the immediate financial outcomes of this investment may not be quantifiable, the long-term benefits of establishing deeper community ties can translate into market resilience and sustained growth for Gilead Sciences.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
– Grants to Strengthen Prevention Models and Local Systems of Care Nationwide –
Gilead Foundation today announced a $12 million investment in 33 community?based organizations across 14 states and the District of Columbia through its Community Health Worker (CHW) Comprehensive HIV Prevention Initiative. This two?year effort expands CHW?led prevention models that strengthen knowledge, care navigation, and access to services for communities disproportionately affected by HIV.
“Community health workers are often the first and most trusted point of connection for people seeking information, support and care,” said Keeley Cain Wettan, Executive Vice President, General Counsel, Legal and Compliance at Gilead Sciences and a Board Member of Gilead Foundation. “Advancing HIV prevention requires both medical innovation and strong, community-led systems that address the social and structural barriers people face every day. By investing in community-based organizations, we’re helping expand access to trusted information, screenings, and culturally responsive care that can drive more equitable health outcomes.”
The initiative also strengthens organizational infrastructure and CHW training systems to build sustainable, locally driven HIV?prevention networks. It prioritizes communities most impacted by HIV—including Black and Latino communities who have sex with men (MSM); cisgender and transgender women; people who inject drugs; and youth—by delivering tailored education and prevention services.
The 33 recipient organizations represent a diverse range of communities facing ongoing HIV prevention challenges. Awardees demonstrate strong community trust, thoughtful program design, and clear plans for measurable impact. Many will use culturally aligned approaches such as promotores models, support, and navigation services within Latino communities, along with peer ambassadors and youth?focused programming.
Philadelphia?based grantee Bebashi – Transition to Hope, which works to advance health equity in the communities it serves, shared its enthusiasm for the initiative. “Bebashi is ecstatic to receive this grant from Gilead Foundation which will strengthen our efforts through the Community Health Worker Initiative,” said Frank Franklin, Ph.D., J.D., M.P.H., FCPP, Chief of Strategic Initiatives. “Community health worker professionals complement Bebashi’s mission of community responsiveness and holistic support.”
Over the next two years, funded organizations will work to:
- Expand integrated screening for HIV, STIs, mental health, and substance use
- Deliver targeted HIV prevention education
- Connect people to services, including HIV prevention, harm reduction resources, and other supportive care
- Reduce stigma and strengthen community engagement through trusted massagers
Grantee Allies in Hope, a Houston?based nonprofit providing HIV prevention, testing, and supportive services to communities disproportionately impacted by HIV, emphasized the role of connection in prevention. “When communities are supported, informed, and empowered, pathways to hope become pathways to healing,” said Jeffrey Campbell, Chief Executive Officer. “Our mission to end the HIV epidemic in the greater Houston area will be significantly bolstered through this funding.”
Many programs will also strengthen the community health workforce through peer navigator models, apprenticeships, pharmacy?based training, and community health integration across care settings, building long?term capacity beyond the grant period.
Grantees | ||
Alabama Five Horizons Health Service Thrive Alabama Arizona Association (NPhA) Prisma Community Care National Pharmaceutical California Bienestar Human Services Realistic Education in Action Coalition to Foster Health (R.E.A.C.H. LA) St. John’s Community Health The TransLatin@ Coalition Colorado Servicios de La Raza Florida LGBT+ Center Orlando Oceana Community Health, Inc Prevention 305 The Poverello Center, Inc. | Georgia NAESM, Inc Illinois Chicago Family Clinic, Inc Louisiana CrescentCare Michigan Community Health Awareness Group (CHAG) New York Callen-Lorde Community Health Center Voces Latinas Corporation Cicatelli Associates, Inc. (CAI) programs nationwide Gay Men’s Health Crisis (GMHC) Trillium Health, Inc | Ohio Equitas Health Pennsylvania Bebashi – Transition to Hope Mazzoni Center Texas Abounding Prosperity, Inc. Allies in Hope Prism Health North Texas PILLAR Resource Center of Dallas, Inc. Washington, DC La Clínica del Pueblo, Inc. Whitman-Walker Health |
About the Gilead Foundation
The Gilead Foundation is a nonprofit organization that works to create a thriving health ecosystem. The Gilead Foundation takes a holistic approach to mitigate the root causes of health inequities by providing resources to organizations that empower people with the skills to be their own best advocate and create systems of support that strengthen communities, classrooms and workplaces
About Gilead Sciences
Gilead Sciences, Inc. (Nasdaq: GILD) is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, cancer and inflammation. In 2025, Gilead announced a planned $32 billion investment to further strengthen its U.S. footprint to power the next era of discovery, job creation and public health preparedness – while continuing to invest globally to ensure patients everywhere benefit from its scientific innovation. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, Calif.
For more information about Gilead, please visit the company’s website at www.gilead.com , follow Gilead on X/Twitter (@Gilead Sciences) and LinkedIn (@Gilead-Sciences).
View source version on businesswire.com: https://www.businesswire.com/news/home/20260302007593/en/
Elizabeth Baxter, Media
public_affairs@gilead.com
Jacquie Ross, Investors
investor_relations@gilead.com
FAQ**
How does Gilead Sciences Inc. GILD plan to measure the success and impact of its $million investment in community-based organizations focused on HIV prevention over the next two years?
What specific challenges in HIV prevention does Gilead Sciences Inc. GILD hope to address through this initiative, especially regarding underserved communities?
Can you elaborate on the long-term vision Gilead Sciences Inc. GILD has for the community health worker model and how it integrates with existing healthcare systems to improve outcomes?
How does Gilead Sciences Inc. GILD ensure that the organizations receiving funding are effectively equipped to implement culturally responsive care and services in their communities?
**MWN-AI FAQ is based on asking OpenAI questions about Gilead Sciences Inc. (NASDAQ: GILD).
NASDAQ: GILD
GILD Trading
0.29% G/L:
$144.365 Last:
664,248 Volume:
$143.50 Open:
